Keywords: ligand, sells, oncology, line, eisai, avinza, king

Ligand sells oncology line to Eisai and Avinza to King for total $518M

Article | 18 September 2006

Print This

San Diego, USA-based Ligand Pharmaceuticals says that it has signed a definitive agreement to sell its oncology product line and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in